arrow
M

Matthew J. Maurer

Mayo Clinic
H指数:85
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies

脾边缘区淋巴瘤987例患者的临床特征、治疗及长期预后分析以指导治疗和监测策略

2026-11-090
OA
The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL

晚期复发的基准分子特征:识别弥漫性大B细胞淋巴瘤延迟复发的驱动因素

2026-10-130
OAAI
Long-term survival and cause-specific mortality after event-free survival at 24 months (EFS24) in mantle cell lymphoma: an international multicohort study

套细胞淋巴瘤在24个月无事件生存期(EFS24)后的长期生存和特定病因死亡率:一项国际多队列研究

2026-09-220
OAAI
Treatment patterns and outcomes for second-line therapy in large B-cell lymphoma: results from the LEO CReWE study

大B细胞淋巴瘤二线治疗的治疗模式与疗效:LEO CReWE研究的结果

2026-07-230
OA
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

开发并验证弥漫性大B细胞淋巴瘤的新型无条件事件生存工具

2026-06-040
PRE
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton’s tyrosine kinase inhibitor therapy

套细胞淋巴瘤在序贯一线 bendamustine-rituximab 和二线 Bruton 酪氨酸激酶抑制剂治疗后的预后

2026-04-250
OAAI
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes

血清中高水平的可溶性肿瘤坏死因子受体2与主要淋巴瘤亚型的不良总生存期相关

2026-03-270
PRE
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study

系统性外周T细胞淋巴瘤的治疗模式与临床结局:LEO-MER前瞻性队列研究

2026-02-200
OAAI
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

2024年国际滤泡性淋巴瘤科学研讨会共识建议

2025-12-050
OAAI
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study
2025-11-010
PRE
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort

自评生成的Charlson合并症指数在淋巴瘤结局流行病学(LEO)队列中的适应性和表现

2025-10-070
PRE
Development and Validation of a Gene Expression Signature to Predict Early Events in Patients with Follicular Lymphoma

开发和验证一种用于预测滤泡性淋巴瘤患者早期事件的基因表达谱

2025-09-220
OAAI
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts

滤泡性淋巴瘤3B亚型具有不同的预后结局:来自前瞻性多中心MER和LEO队列的研究结果

2025-08-080
OAAI
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

整合基因组学与精细的细胞起源亚型划分,区分了弥漫性大B细胞淋巴瘤中特定亚型的治疗抵抗和复发机制。

2025-07-120
OAAI
The Phenotypic Landscape of Anaplastic Large Cell Lymphoma Supports a New Molecular Classification: An LLMPP Study

间变性大细胞淋巴瘤的表型景观支持新的分子分类: 一项LLMPP研究

2025-03-010
PRE